

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.64783380 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.46394729 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.38187953 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.26772790 |
| 5 | vocalization behavior (GO:0071625) | 5.99792398 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.75135336 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.68079082 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.66783409 |
| 9 | glutamate secretion (GO:0014047) | 5.64879200 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.60216729 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.24360987 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.23104951 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.08268459 |
| 14 | protein localization to synapse (GO:0035418) | 4.96680656 |
| 15 | exploration behavior (GO:0035640) | 4.84895411 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.81121425 |
| 17 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.77300087 |
| 18 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.77157822 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.68144847 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.65184243 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.62724837 |
| 22 | glutamate receptor signaling pathway (GO:0007215) | 4.51874379 |
| 23 | neuron cell-cell adhesion (GO:0007158) | 4.49738508 |
| 24 | dendritic spine morphogenesis (GO:0060997) | 4.49149740 |
| 25 | regulation of synapse structural plasticity (GO:0051823) | 4.46815950 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.37667020 |
| 27 | layer formation in cerebral cortex (GO:0021819) | 4.30591256 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.27612755 |
| 29 | positive regulation of membrane potential (GO:0045838) | 4.21833492 |
| 30 | neuron-neuron synaptic transmission (GO:0007270) | 4.21604294 |
| 31 | cellular potassium ion homeostasis (GO:0030007) | 4.21489538 |
| 32 | long-term memory (GO:0007616) | 4.18301609 |
| 33 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.15938158 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 4.15830004 |
| 35 | potassium ion homeostasis (GO:0055075) | 4.09839342 |
| 36 | amino acid import (GO:0043090) | 4.06209367 |
| 37 | proline transport (GO:0015824) | 4.03808334 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.99885501 |
| 39 | regulation of postsynaptic membrane potential (GO:0060078) | 3.96763863 |
| 40 | positive regulation of synapse maturation (GO:0090129) | 3.95157854 |
| 41 | sodium ion export (GO:0071436) | 3.92689639 |
| 42 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.89510930 |
| 43 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.84426503 |
| 44 | central nervous system myelination (GO:0022010) | 3.80129448 |
| 45 | axon ensheathment in central nervous system (GO:0032291) | 3.80129448 |
| 46 | regulation of synaptic plasticity (GO:0048167) | 3.80092007 |
| 47 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.76659438 |
| 48 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.73346062 |
| 49 | neurotransmitter transport (GO:0006836) | 3.72089015 |
| 50 | neuromuscular process controlling balance (GO:0050885) | 3.71264706 |
| 51 | potassium ion import (GO:0010107) | 3.68750107 |
| 52 | regulation of neurotransmitter secretion (GO:0046928) | 3.66344219 |
| 53 | synaptic vesicle endocytosis (GO:0048488) | 3.65237722 |
| 54 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.57355974 |
| 55 | auditory behavior (GO:0031223) | 3.55719108 |
| 56 | activation of protein kinase A activity (GO:0034199) | 3.55426664 |
| 57 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.54901474 |
| 58 | cellular sodium ion homeostasis (GO:0006883) | 3.53140455 |
| 59 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.52152179 |
| 60 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.51692297 |
| 61 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.50891220 |
| 62 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.50525267 |
| 63 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.48266499 |
| 64 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.47474301 |
| 65 | transmission of nerve impulse (GO:0019226) | 3.46880117 |
| 66 | regulation of neurotransmitter levels (GO:0001505) | 3.46489716 |
| 67 | neuromuscular synaptic transmission (GO:0007274) | 3.46421450 |
| 68 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.45089199 |
| 69 | presynaptic membrane organization (GO:0097090) | 3.44225982 |
| 70 | long-term synaptic potentiation (GO:0060291) | 3.43918855 |
| 71 | membrane depolarization during action potential (GO:0086010) | 3.43097174 |
| 72 | membrane depolarization (GO:0051899) | 3.41678918 |
| 73 | postsynaptic membrane organization (GO:0001941) | 3.41654549 |
| 74 | neuron recognition (GO:0008038) | 3.41512539 |
| 75 | neuromuscular process controlling posture (GO:0050884) | 3.40871149 |
| 76 | presynaptic membrane assembly (GO:0097105) | 3.38597147 |
| 77 | positive regulation of neurotransmitter transport (GO:0051590) | 3.37011878 |
| 78 | cell differentiation in hindbrain (GO:0021533) | 3.35906849 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.35842428 |
| 80 | membrane hyperpolarization (GO:0060081) | 3.35600613 |
| 81 | response to auditory stimulus (GO:0010996) | 3.35224993 |
| 82 | dendrite morphogenesis (GO:0048813) | 3.31317853 |
| 83 | cell communication by electrical coupling (GO:0010644) | 3.30976738 |
| 84 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.30834169 |
| 85 | regulation of ARF protein signal transduction (GO:0032012) | 3.30703115 |
| 86 | dendritic spine organization (GO:0097061) | 3.29582783 |
| 87 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.28595573 |
| 88 | cerebellar granule cell differentiation (GO:0021707) | 3.28422047 |
| 89 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.27771960 |
| 90 | glycine transport (GO:0015816) | 3.27670220 |
| 91 | regulation of vesicle fusion (GO:0031338) | 3.27054619 |
| 92 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.26136638 |
| 93 | L-amino acid import (GO:0043092) | 3.23113058 |
| 94 | axonal fasciculation (GO:0007413) | 3.22823011 |
| 95 | establishment of mitochondrion localization (GO:0051654) | 3.22392009 |
| 96 | prepulse inhibition (GO:0060134) | 3.22214452 |
| 97 | cell migration in hindbrain (GO:0021535) | 3.20368960 |
| 98 | regulation of dendritic spine development (GO:0060998) | 3.18865906 |
| 99 | positive regulation of dendritic spine development (GO:0060999) | 3.17911620 |
| 100 | learning (GO:0007612) | 3.16921529 |
| 101 | innervation (GO:0060384) | 3.15091806 |
| 102 | chemosensory behavior (GO:0007635) | 3.14964994 |
| 103 | * synaptic transmission (GO:0007268) | 3.14450320 |
| 104 | intraspecies interaction between organisms (GO:0051703) | 3.12735731 |
| 105 | social behavior (GO:0035176) | 3.12735731 |
| 106 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.12416969 |
| 107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.11430505 |
| 108 | regulation of synaptic transmission (GO:0050804) | 3.10989406 |
| 109 | neuromuscular process (GO:0050905) | 3.10895383 |
| 110 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.09010403 |
| 111 | positive regulation of synaptic transmission (GO:0050806) | 3.07532939 |
| 112 | neuronal ion channel clustering (GO:0045161) | 3.07285192 |
| 113 | acidic amino acid transport (GO:0015800) | 3.05574301 |
| 114 | behavioral fear response (GO:0001662) | 3.04611607 |
| 115 | behavioral defense response (GO:0002209) | 3.04611607 |
| 116 | response to histamine (GO:0034776) | 3.04207878 |
| 117 | synapse assembly (GO:0007416) | 3.03620171 |
| 118 | regulation of synapse maturation (GO:0090128) | 3.03177652 |
| 119 | adult walking behavior (GO:0007628) | 3.02656125 |
| 120 | synaptic vesicle transport (GO:0048489) | 3.01411433 |
| 121 | establishment of synaptic vesicle localization (GO:0097480) | 3.01411433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.31510111 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.43808250 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.16850526 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.16224434 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.10206399 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.90089702 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.87219969 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.81373938 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.81373938 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.79821163 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.70009757 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59897041 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.56820799 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55684732 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53040711 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47106094 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43802900 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.32874077 |
| 19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.32428726 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.31954417 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.27724942 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.27692417 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24437253 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.23643205 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.20067509 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.10357237 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.02067233 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95024613 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83853576 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83389036 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76763962 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71135695 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.67292689 |
| 34 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57927564 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56759717 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47778778 |
| 37 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.37647481 |
| 38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34875149 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33989371 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33967384 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33741801 |
| 42 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29610526 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28145646 |
| 44 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.27863749 |
| 45 | AR_19668381_ChIP-Seq_PC3_Human | 1.26544355 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.25931015 |
| 47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25598124 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25381361 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23123794 |
| 50 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.22786941 |
| 51 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21389413 |
| 52 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.21210058 |
| 53 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.20394875 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20240652 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20167002 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20126266 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19951680 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19817382 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.17565273 |
| 60 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.15625814 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15275341 |
| 62 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13260720 |
| 63 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12382443 |
| 64 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09440356 |
| 65 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08964358 |
| 66 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08789506 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08691272 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06965651 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06759124 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06380407 |
| 71 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05243037 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05122268 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03363425 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03282017 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02813845 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.02389577 |
| 77 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01640405 |
| 78 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.01337529 |
| 79 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99253820 |
| 80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98015037 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97106222 |
| 82 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96715593 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96667308 |
| 84 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96623894 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96463783 |
| 86 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96165936 |
| 87 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94608340 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94084230 |
| 89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93877666 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93772499 |
| 91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93504563 |
| 92 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93074396 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92724601 |
| 94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92001471 |
| 95 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91719798 |
| 96 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91694687 |
| 97 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91641297 |
| 98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91169390 |
| 99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90469003 |
| 100 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.90356892 |
| 101 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90218478 |
| 102 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89553453 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89059707 |
| 104 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88705089 |
| 105 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88462782 |
| 106 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.87933827 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87729036 |
| 108 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.87039858 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.86687706 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86687706 |
| 111 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.86608681 |
| 112 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85224880 |
| 113 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.84451110 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82208280 |
| 115 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79156977 |
| 116 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.77233966 |
| 117 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.76989688 |
| 118 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76708207 |
| 119 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.75240172 |
| 120 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.74866236 |
| 121 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74422663 |
| 122 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.74121766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.36076754 |
| 2 | MP0003880_abnormal_central_pattern | 4.69181542 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.39171694 |
| 4 | MP0004270_analgesia | 3.97662183 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.50190078 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.47893336 |
| 7 | * MP0002064_seizures | 3.26304003 |
| 8 | * MP0009046_muscle_twitch | 3.19004029 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.14244895 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.99146181 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.90900539 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.77920948 |
| 13 | MP0002822_catalepsy | 2.73725323 |
| 14 | MP0001486_abnormal_startle_reflex | 2.68971326 |
| 15 | * MP0002272_abnormal_nervous_system | 2.66644167 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.39735229 |
| 17 | MP0002736_abnormal_nociception_after | 2.32624047 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.29105489 |
| 19 | MP0008569_lethality_at_weaning | 2.18256805 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.10184990 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.03556468 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.03017142 |
| 23 | MP0002067_abnormal_sensory_capabilities | 2.01480115 |
| 24 | MP0001970_abnormal_pain_threshold | 1.98525136 |
| 25 | MP0004858_abnormal_nervous_system | 1.90379471 |
| 26 | MP0004811_abnormal_neuron_physiology | 1.89411856 |
| 27 | MP0002184_abnormal_innervation | 1.85704949 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.80639057 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.75741505 |
| 30 | MP0004924_abnormal_behavior | 1.75741505 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.72587803 |
| 32 | MP0003329_amyloid_beta_deposits | 1.71330302 |
| 33 | MP0000778_abnormal_nervous_system | 1.70133516 |
| 34 | MP0003123_paternal_imprinting | 1.69965049 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.66126887 |
| 36 | MP0000955_abnormal_spinal_cord | 1.54977271 |
| 37 | MP0001984_abnormal_olfaction | 1.54703633 |
| 38 | MP0003633_abnormal_nervous_system | 1.48012422 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.44192225 |
| 40 | MP0004885_abnormal_endolymph | 1.43772187 |
| 41 | * MP0002066_abnormal_motor_capabilities/c | 1.43762299 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.43280015 |
| 43 | MP0003787_abnormal_imprinting | 1.40749320 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.39887059 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.39875711 |
| 46 | * MP0003879_abnormal_hair_cell | 1.30761257 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.25688342 |
| 48 | MP0003631_nervous_system_phenotype | 1.23851123 |
| 49 | MP0004142_abnormal_muscle_tone | 1.17472001 |
| 50 | MP0008872_abnormal_physiological_respon | 1.14591923 |
| 51 | MP0001905_abnormal_dopamine_level | 1.11771710 |
| 52 | MP0002152_abnormal_brain_morphology | 1.11009766 |
| 53 | MP0001348_abnormal_lacrimal_gland | 1.09484033 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.07740466 |
| 55 | MP0001529_abnormal_vocalization | 1.06311569 |
| 56 | MP0003075_altered_response_to | 1.04684219 |
| 57 | MP0008874_decreased_physiological_sensi | 1.00338662 |
| 58 | MP0003121_genomic_imprinting | 0.98800240 |
| 59 | MP0002229_neurodegeneration | 0.97536753 |
| 60 | MP0008961_abnormal_basal_metabolism | 0.96485090 |
| 61 | MP0002069_abnormal_eating/drinking_beha | 0.95307613 |
| 62 | MP0003122_maternal_imprinting | 0.94791510 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 0.93381688 |
| 64 | MP0001188_hyperpigmentation | 0.92555071 |
| 65 | MP0004742_abnormal_vestibular_system | 0.92202381 |
| 66 | MP0008877_abnormal_DNA_methylation | 0.91318156 |
| 67 | MP0001177_atelectasis | 0.90507463 |
| 68 | MP0003283_abnormal_digestive_organ | 0.90372380 |
| 69 | MP0004147_increased_porphyrin_level | 0.87667657 |
| 70 | MP0003632_abnormal_nervous_system | 0.87437021 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.85976685 |
| 72 | MP0003690_abnormal_glial_cell | 0.85631832 |
| 73 | MP0000751_myopathy | 0.82929286 |
| 74 | MP0004510_myositis | 0.82086802 |
| 75 | MP0004085_abnormal_heartbeat | 0.81338007 |
| 76 | MP0000920_abnormal_myelination | 0.79940534 |
| 77 | MP0010386_abnormal_urinary_bladder | 0.79825817 |
| 78 | MP0005535_abnormal_body_temperature | 0.79481705 |
| 79 | MP0005499_abnormal_olfactory_system | 0.76774906 |
| 80 | MP0005394_taste/olfaction_phenotype | 0.76774906 |
| 81 | MP0003634_abnormal_glial_cell | 0.75574740 |
| 82 | MP0001346_abnormal_lacrimal_gland | 0.73664188 |
| 83 | MP0000604_amyloidosis | 0.73503074 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.70283330 |
| 85 | * MP0001963_abnormal_hearing_physiology | 0.70141042 |
| 86 | MP0002090_abnormal_vision | 0.69301412 |
| 87 | MP0002752_abnormal_somatic_nervous | 0.67755695 |
| 88 | MP0001485_abnormal_pinna_reflex | 0.67287408 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 0.66494906 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.66111027 |
| 91 | MP0005409_darkened_coat_color | 0.64714350 |
| 92 | MP0004215_abnormal_myocardial_fiber | 0.64123229 |
| 93 | MP0004130_abnormal_muscle_cell | 0.64072878 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.63366859 |
| 95 | MP0004484_altered_response_of | 0.58887005 |
| 96 | MP0001664_abnormal_digestion | 0.58507949 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.58117611 |
| 98 | MP0010769_abnormal_survival | 0.57208448 |
| 99 | MP0004233_abnormal_muscle_weight | 0.56416330 |
| 100 | MP0002638_abnormal_pupillary_reflex | 0.55828403 |
| 101 | MP0010768_mortality/aging | 0.53870415 |
| 102 | MP0010770_preweaning_lethality | 0.53514229 |
| 103 | MP0002082_postnatal_lethality | 0.53514229 |
| 104 | MP0003861_abnormal_nervous_system | 0.52671959 |
| 105 | MP0005623_abnormal_meninges_morphology | 0.52494098 |
| 106 | MP0001943_abnormal_respiration | 0.52273606 |
| 107 | MP0002249_abnormal_larynx_morphology | 0.51924846 |
| 108 | MP0000026_abnormal_inner_ear | 0.51784588 |
| 109 | MP0003045_fibrosis | 0.51718444 |
| 110 | MP0003956_abnormal_body_size | 0.50900172 |
| 111 | MP0004043_abnormal_pH_regulation | 0.50229616 |
| 112 | MP0002089_abnormal_postnatal_growth/wei | 0.45642328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.94058842 |
| 2 | Myokymia (HP:0002411) | 7.51610731 |
| 3 | Focal seizures (HP:0007359) | 6.20210371 |
| 4 | Visual hallucinations (HP:0002367) | 5.64200607 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.08234644 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.97440758 |
| 7 | Action tremor (HP:0002345) | 4.71542257 |
| 8 | Febrile seizures (HP:0002373) | 4.68301663 |
| 9 | Atonic seizures (HP:0010819) | 4.52089490 |
| 10 | Absence seizures (HP:0002121) | 4.22943553 |
| 11 | Gaze-evoked nystagmus (HP:0000640) | 4.06003038 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.97476058 |
| 13 | Broad-based gait (HP:0002136) | 3.91818606 |
| 14 | Dialeptic seizures (HP:0011146) | 3.86875512 |
| 15 | Poor eye contact (HP:0000817) | 3.79638425 |
| 16 | Ankle clonus (HP:0011448) | 3.55096979 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.53362086 |
| 18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.53132698 |
| 19 | Dysdiadochokinesis (HP:0002075) | 3.45607425 |
| 20 | Depression (HP:0000716) | 3.42082581 |
| 21 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.37189452 |
| 22 | Impaired social interactions (HP:0000735) | 3.36283488 |
| 23 | Abnormal social behavior (HP:0012433) | 3.36283488 |
| 24 | Impaired smooth pursuit (HP:0007772) | 3.33140076 |
| 25 | Dysmetria (HP:0001310) | 3.33125905 |
| 26 | Papilledema (HP:0001085) | 3.30003019 |
| 27 | Truncal ataxia (HP:0002078) | 3.28473238 |
| 28 | Genetic anticipation (HP:0003743) | 3.27837306 |
| 29 | Postural instability (HP:0002172) | 3.20120155 |
| 30 | Mutism (HP:0002300) | 3.11082984 |
| 31 | Cerebral hypomyelination (HP:0006808) | 3.09250176 |
| 32 | Anxiety (HP:0000739) | 3.06547489 |
| 33 | Hyperventilation (HP:0002883) | 3.06442954 |
| 34 | Abnormality of the lower motor neuron (HP:0002366) | 2.98593514 |
| 35 | Scanning speech (HP:0002168) | 2.96810849 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.93617180 |
| 37 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.92925739 |
| 38 | Amblyopia (HP:0000646) | 2.91068771 |
| 39 | Akinesia (HP:0002304) | 2.89994351 |
| 40 | Hemiplegia (HP:0002301) | 2.88720461 |
| 41 | Intention tremor (HP:0002080) | 2.83633637 |
| 42 | Dysmetric saccades (HP:0000641) | 2.82982253 |
| 43 | Urinary urgency (HP:0000012) | 2.75677890 |
| 44 | Sleep apnea (HP:0010535) | 2.75304147 |
| 45 | Hemiparesis (HP:0001269) | 2.73344775 |
| 46 | Abnormality of binocular vision (HP:0011514) | 2.70413107 |
| 47 | Diplopia (HP:0000651) | 2.70413107 |
| 48 | Spastic gait (HP:0002064) | 2.69774233 |
| 49 | Torticollis (HP:0000473) | 2.69148434 |
| 50 | Stereotypic behavior (HP:0000733) | 2.68733839 |
| 51 | Drooling (HP:0002307) | 2.64221741 |
| 52 | Excessive salivation (HP:0003781) | 2.64221741 |
| 53 | Bradykinesia (HP:0002067) | 2.56724118 |
| 54 | Focal dystonia (HP:0004373) | 2.55947961 |
| 55 | Epileptiform EEG discharges (HP:0011182) | 2.50545548 |
| 56 | Impaired vibratory sensation (HP:0002495) | 2.49100997 |
| 57 | Ventricular fibrillation (HP:0001663) | 2.48660739 |
| 58 | Annular pancreas (HP:0001734) | 2.44026711 |
| 59 | Status epilepticus (HP:0002133) | 2.39521012 |
| 60 | Fetal akinesia sequence (HP:0001989) | 2.38648859 |
| 61 | EEG with generalized epileptiform discharges (HP:0011198) | 2.37810836 |
| 62 | Absent speech (HP:0001344) | 2.32177289 |
| 63 | Pointed chin (HP:0000307) | 2.30181444 |
| 64 | Progressive inability to walk (HP:0002505) | 2.29455952 |
| 65 | Megalencephaly (HP:0001355) | 2.27232971 |
| 66 | Peripheral hypomyelination (HP:0007182) | 2.27224607 |
| 67 | Hypsarrhythmia (HP:0002521) | 2.24498738 |
| 68 | Spastic tetraparesis (HP:0001285) | 2.21106696 |
| 69 | Craniofacial dystonia (HP:0012179) | 2.19436572 |
| 70 | Agitation (HP:0000713) | 2.16625014 |
| 71 | Delusions (HP:0000746) | 2.15605454 |
| 72 | Insomnia (HP:0100785) | 2.14733686 |
| 73 | Abnormality of the corticospinal tract (HP:0002492) | 2.13532590 |
| 74 | Neurofibrillary tangles (HP:0002185) | 2.12544901 |
| 75 | Lower limb muscle weakness (HP:0007340) | 2.12326211 |
| 76 | Cerebral inclusion bodies (HP:0100314) | 2.11918099 |
| 77 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.11335237 |
| 78 | Obstructive sleep apnea (HP:0002870) | 2.10443856 |
| 79 | Insidious onset (HP:0003587) | 2.09415091 |
| 80 | Termporal pattern (HP:0011008) | 2.09415091 |
| 81 | Gait ataxia (HP:0002066) | 2.08003223 |
| 82 | Abnormality of saccadic eye movements (HP:0000570) | 2.07204314 |
| 83 | Generalized myoclonic seizures (HP:0002123) | 2.07013825 |
| 84 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.05311688 |
| 85 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.05311688 |
| 86 | Incomplete penetrance (HP:0003829) | 2.04616852 |
| 87 | Choreoathetosis (HP:0001266) | 2.04063579 |
| 88 | Inability to walk (HP:0002540) | 2.02415201 |
| 89 | Pheochromocytoma (HP:0002666) | 1.98891208 |
| 90 | Inappropriate behavior (HP:0000719) | 1.98624902 |
| 91 | Bundle branch block (HP:0011710) | 1.97933236 |
| 92 | Limb dystonia (HP:0002451) | 1.96977382 |
| 93 | CNS hypomyelination (HP:0003429) | 1.95886082 |
| 94 | Clonus (HP:0002169) | 1.95611718 |
| 95 | Diminished motivation (HP:0000745) | 1.91278581 |
| 96 | Lower limb amyotrophy (HP:0007210) | 1.90244415 |
| 97 | Amyotrophic lateral sclerosis (HP:0007354) | 1.90142248 |
| 98 | Blue irides (HP:0000635) | 1.87222835 |
| 99 | Polyphagia (HP:0002591) | 1.86840460 |
| 100 | Neuronal loss in central nervous system (HP:0002529) | 1.85795752 |
| 101 | Rigidity (HP:0002063) | 1.84002290 |
| 102 | Lower limb asymmetry (HP:0100559) | 1.83271812 |
| 103 | Abnormal EKG (HP:0003115) | 1.83175894 |
| 104 | Rapidly progressive (HP:0003678) | 1.82878396 |
| 105 | Psychosis (HP:0000709) | 1.80121957 |
| 106 | Protruding tongue (HP:0010808) | 1.78856855 |
| 107 | Limb ataxia (HP:0002070) | 1.78851949 |
| 108 | Spastic tetraplegia (HP:0002510) | 1.78299361 |
| 109 | Abnormality of the periventricular white matter (HP:0002518) | 1.76196247 |
| 110 | Abnormality of salivation (HP:0100755) | 1.74842916 |
| 111 | Bronchomalacia (HP:0002780) | 1.74008245 |
| 112 | Ankyloglossia (HP:0010296) | 1.73912377 |
| 113 | Prolonged QT interval (HP:0001657) | 1.71955343 |
| 114 | Tetraplegia (HP:0002445) | 1.71611381 |
| 115 | Spinal canal stenosis (HP:0003416) | 1.71193665 |
| 116 | Apathy (HP:0000741) | 1.69972287 |
| 117 | Turricephaly (HP:0000262) | 1.68000723 |
| 118 | Increased circulating renin level (HP:0000848) | 1.64036089 |
| 119 | Hypoplasia of the corpus callosum (HP:0002079) | 1.63851343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.65248082 |
| 2 | EPHA4 | 4.39549486 |
| 3 | MAP3K9 | 4.09675759 |
| 4 | DAPK2 | 2.97272982 |
| 5 | MARK1 | 2.92127847 |
| 6 | MAP3K4 | 2.85914991 |
| 7 | MINK1 | 2.70322444 |
| 8 | PAK6 | 2.50489231 |
| 9 | MAP2K7 | 2.36616235 |
| 10 | PRKD3 | 2.30405083 |
| 11 | NTRK2 | 2.28373828 |
| 12 | CAMKK1 | 2.17388840 |
| 13 | RIPK4 | 2.00832073 |
| 14 | KSR2 | 1.96603599 |
| 15 | NTRK1 | 1.96507583 |
| 16 | DAPK1 | 1.88174879 |
| 17 | MAP2K4 | 1.79947488 |
| 18 | MAP3K12 | 1.77551990 |
| 19 | CDK5 | 1.62147798 |
| 20 | SIK2 | 1.60960472 |
| 21 | CDK19 | 1.57020106 |
| 22 | TNIK | 1.55510546 |
| 23 | KSR1 | 1.54766681 |
| 24 | PRPF4B | 1.52904281 |
| 25 | STK38 | 1.50042104 |
| 26 | CAMKK2 | 1.43223202 |
| 27 | CASK | 1.36771355 |
| 28 | GRK5 | 1.33039852 |
| 29 | MAPK13 | 1.31119395 |
| 30 | PLK2 | 1.26923911 |
| 31 | FES | 1.23904939 |
| 32 | PRKCG | 1.23078831 |
| 33 | CAMK1 | 1.22984962 |
| 34 | TAOK1 | 1.16334662 |
| 35 | UHMK1 | 1.14739821 |
| 36 | MAP3K2 | 1.12678953 |
| 37 | TYRO3 | 1.11639099 |
| 38 | PNCK | 1.08308765 |
| 39 | MAP3K13 | 1.06523081 |
| 40 | ARAF | 1.03487124 |
| 41 | STK11 | 0.99778563 |
| 42 | SGK494 | 0.95801123 |
| 43 | SGK223 | 0.95801123 |
| 44 | CAMK2A | 0.94053456 |
| 45 | CDK18 | 0.93203720 |
| 46 | RIPK1 | 0.92816427 |
| 47 | CDK15 | 0.91976689 |
| 48 | CAMK1D | 0.91184613 |
| 49 | SGK2 | 0.89637419 |
| 50 | PRKCH | 0.88898715 |
| 51 | ALK | 0.86802892 |
| 52 | CDK14 | 0.83678024 |
| 53 | SGK3 | 0.81144478 |
| 54 | CDK11A | 0.80574081 |
| 55 | RET | 0.80450206 |
| 56 | LATS2 | 0.78368161 |
| 57 | RAF1 | 0.76255928 |
| 58 | PHKG1 | 0.75437829 |
| 59 | PHKG2 | 0.75437829 |
| 60 | CAMK2B | 0.75408773 |
| 61 | PKN1 | 0.74115907 |
| 62 | PTK2B | 0.73657445 |
| 63 | FGFR2 | 0.73409700 |
| 64 | MARK2 | 0.72984992 |
| 65 | PDK1 | 0.72711768 |
| 66 | PAK3 | 0.71774848 |
| 67 | PINK1 | 0.67995198 |
| 68 | BMPR2 | 0.66733187 |
| 69 | CAMK1G | 0.65694724 |
| 70 | OXSR1 | 0.65215409 |
| 71 | CAMK4 | 0.64793224 |
| 72 | TNK2 | 0.63549563 |
| 73 | DYRK1A | 0.62603322 |
| 74 | * SGK1 | 0.61825305 |
| 75 | PDPK1 | 0.59605751 |
| 76 | MAP3K7 | 0.57263794 |
| 77 | CSNK1G2 | 0.56532278 |
| 78 | CCNB1 | 0.56213604 |
| 79 | BRAF | 0.52815006 |
| 80 | SCYL2 | 0.52462044 |
| 81 | MAP3K1 | 0.51962196 |
| 82 | LMTK2 | 0.51753688 |
| 83 | * RPS6KA3 | 0.51643454 |
| 84 | SIK3 | 0.51489990 |
| 85 | CDC42BPA | 0.49626649 |
| 86 | FYN | 0.49443276 |
| 87 | PRKCZ | 0.48569135 |
| 88 | NEK6 | 0.48192043 |
| 89 | BRSK1 | 0.48137390 |
| 90 | WNK1 | 0.45873522 |
| 91 | MAPK10 | 0.43736626 |
| 92 | DAPK3 | 0.42962353 |
| 93 | ERBB2 | 0.39661546 |
| 94 | CAMK2G | 0.38681668 |
| 95 | MAP3K11 | 0.37906682 |
| 96 | LIMK1 | 0.36881240 |
| 97 | CAMK2D | 0.36589348 |
| 98 | ICK | 0.36228070 |
| 99 | NEK1 | 0.36130091 |
| 100 | PRKCE | 0.35013194 |
| 101 | ROCK2 | 0.34043566 |
| 102 | DMPK | 0.33529015 |
| 103 | PRKG1 | 0.33210744 |
| 104 | DYRK2 | 0.32729130 |
| 105 | CSNK1D | 0.32637664 |
| 106 | MAP3K6 | 0.32608649 |
| 107 | * MAPK8 | 0.31812487 |
| 108 | * GSK3B | 0.31689213 |
| 109 | PRKAA1 | 0.31329699 |
| 110 | MAP2K1 | 0.30115617 |
| 111 | RPS6KA2 | 0.29627898 |
| 112 | * PRKCB | 0.29551348 |
| 113 | PRKACA | 0.29297220 |
| 114 | WNK3 | 0.28903690 |
| 115 | MAPK12 | 0.28835132 |
| 116 | PRKCA | 0.28381555 |
| 117 | * CSNK1E | 0.27541295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.76167677 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.31104594 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.82288637 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.79861362 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.76416366 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.74743789 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.68713340 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.65415752 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.51556653 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.47437250 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.28953629 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.24127814 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.14068424 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.11946613 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.99957642 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.98391223 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.97219474 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.71994951 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.71648758 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.70973554 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.69429362 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.65210827 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.61249217 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.60033109 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58473080 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49162665 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47780326 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.38444779 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35595175 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31995967 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.31988491 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29063527 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28290466 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24496595 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.20825404 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18696649 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.16468495 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11788153 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11234448 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09684759 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07618189 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05845650 |
| 43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03751508 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.03089085 |
| 45 | Melanogenesis_Homo sapiens_hsa04916 | 1.01110177 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94890076 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94073038 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93477832 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90896473 |
| 50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85962440 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83964481 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 0.82456725 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81658171 |
| 54 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80602868 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80440943 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77198827 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75718813 |
| 58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73681067 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72479582 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71386693 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71341441 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71005520 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67771853 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67332740 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66981942 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60714949 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60134784 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59739448 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57812526 |
| 70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56883730 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56580420 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56398268 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53837761 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53237900 |
| 75 | Alcoholism_Homo sapiens_hsa05034 | 0.52669541 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.52218584 |
| 77 | Bile secretion_Homo sapiens_hsa04976 | 0.51010186 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49955225 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49010357 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47632187 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46907317 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46645143 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45398710 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42811289 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42363230 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41248675 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40291154 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39874109 |
| 89 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39033828 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38607884 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37365330 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37314574 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36584139 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35931755 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34791659 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33994876 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33384093 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32904493 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31609224 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31220419 |
| 101 | Mineral absorption_Homo sapiens_hsa04978 | 0.29242552 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.28515431 |
| 103 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.28041791 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.27773599 |
| 105 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27608840 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.27444011 |
| 107 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27166773 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26064485 |
| 109 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.23413955 |
| 110 | Tight junction_Homo sapiens_hsa04530 | 0.22891855 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.18818411 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.18786953 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18061521 |

